Page Banner

Notifications & Alerts

Latest Notifications & Alerts

Starting December 1, 2023, LifeLabs will no longer be supplying gFOBT cards to healthcare providers. Testing using gFOBT will be discontinued in the spring of 2024. Until the test is discontinued, the cards may be picked up by patients at any LifeLabs patient service center.
LifeLabs is experiencing a shortage of H. pylori breath kits due to vendor supply issues. As a result, we will be temporarily unable to offer breath test collection kits for testing. To ensure continued access to testing during this shortage, patients can use the H. pylori stool antigen test as an ...
Serving over 7 million Canadians nationwide, the platform serves to support patients and their health care providers in making informed decisions about their health with an array of digital tools and solutions.
LifeLabs will be transitioning from using a 5.0 mL SST gold top tube to a 3.5 mL SST gold top tube for both, adult and pediatric patients.Know More
Feb 6, 2024

Changes CO2 Testing

Effective March 4th, 2024, specimens for total carbon dioxide ( CO2 ) requests must be collected on a separate SST vacutainer ( gold top tube ) for determination of CO2 ONLY.Know More
Effective February 18th 2024, LifeLabs MRSA and VRE screening tests will change swabs from Amies gel/charcoal swab to Copan eSwab. Know More
Effective February 5, 2024, all thyroglobulin test orders will automatically have an anti-thyroglobulin test added on to the order. Know More
**Delay in Turnaround Time (TAT)** Vasoactive Intestinal Polypeptide (VIP) will temporarily have an increased TAT, due to a supply chain issue with the referral site. The resolution to the delay is expected in early 2024. We apologize for any inconvenience this may cause.
In pursuit of an outstanding digital experience for our customers, we are excited to introduce our new and improved Lab Test Information Database. Know More
LifeLabs is partnering with Klinrisk to exclusively offer an algorithm-based test tool for risk stratification of kidney failure progression at early stages of CKD for at risk patients.
There will be no Panorama™ Non-Invasive Prenatal Test (NIPT) collections on December 25, 26, and January 1.
As of January 1, 2024, the price of Home Care services for homebound patients will increase by $10 to $55, and the price of MyVisit™, a convenience-based service, will increase to $85.
Effective 04 December 2023, serum (SST, gold top) will be the preferred specimen to test for NT-proBNP. There is no change in reference intervals and/or interpretation of test results between the two sample types. Sample transport and storage conditions also remain unchanged. EDTA plasma (lavender t...
We have partnered with LifestyleRx to offer Canadians greater support in managing their health with prediabetes and Type 2 Diabetes
ANCA and ANTI-CCP have been added under the Ministry of Health’s Community Access Pilot program coverage for collection and testing when ordered by select health care specialists in Ontario.
September 30th is National Day for Truth and Reconciliation. Our operations will continue as normal on Saturday the 30th, but we will be closed on Monday, October 2, 2023, to observe the holiday.
Due to a global supply shortage, the enzyme used for oxalate measurement is temporarily unavailable. LifeLabs has limited supply of the reagent and will suspend testing on September 28, 2023 in Ontario, and on October 5, 2023 in B.C.
We’re pleased to share that we have introduced the Enhanced Liver Fibrosis Score (ELFTM) in Ontario as a convenient option for screening for liver fibrosis in Non-alcoholic fatty liver disease (NAFLD) patients.
***Update on Test Ordering [Clarification]*** When ordering Stool Ova & Parasites testing, if helminthic infestation is suspected, the patient has immunocompromised status, or if testing is for immigration/refugee screening purposes, then please collect stool samples in SAF containers. Please provi...
Aug 24, 2023


**Update in Testing** This test is currently unavailable. We apologize for the inconvenience.